| 


|
|
Sunscreens 2000 -- What You Need To Know
FDA Approved Sunscreen Active Ingredients
| Aminobenzoic acid (PABA) |
up to 15 percent |
| Avobenzone |
up to 3 percent |
| Cinoxate |
up to 3 percent |
| Dioxybenzone |
up to 3 percent |
| Homosalate |
up to 15 percent |
| Menthyl anthranilate |
up to 5 percent |
| Octocrylene |
up to 10 percent |
| Octyl methoxycinnamate |
up to 7.5 percent |
| Octyl salicylate |
up to 5 percent |
| Oxybenzone |
up to 6 percent |
| Padimate O |
up to 8 percent |
| Phenylbenzimidazole sulfonic acid |
up to 4 percent |
| Sulisobenzone |
up to 10 percent |
| Titanium dioxide |
up to 25 percent |
| Trolamine salicylate |
up to 12 percent |
| Zinc oxide |
up to 25 percent |
The following figure shows the UV protective absorption spectrums of the FDA
approved sunscreen active ingredients. Combinations of these ingredients at various
concentrations provide the desired SPF protection and UV spectrum of each sunscreen
product, which along with cosmetic bases and other inert ingredients provide the water
stability and final form of the product.

Adapted from Federal Register 43,
38206 - 38269, 1978 and manufacturers product information.
Note: Micronized forms of titanium dioxide and zinc
oxide do not block the entire range of ultraviolet radiation up to 700 nm. In their
previous opaque formulations, they were considered opaque sun blockers that scattered
light from 200 nm to 700 nm, but in their new transparent micronized forms, they are
considered to absorb UV radiation and have a much narrower spectrum limited to mid-UV-C,
UV-B, and UV-A. Micronized zinc oxide has a wider UV spectrum than micronized
titanium dioxide. Depending on the manufacturer, micronized zinc oxide can absorb
UV-A radiation up to 380 nm or 400 nm. Likewise, the UV absorption of micronized or
microfine titanium dioxide extends to 350 nm or 370 nm depending on the manufacturer.
Neither zinc oxide nor titanium dioxide are absorbed by intact skin.
As can be seen in the figure, Avobenzone (Parsol
1789) combined with micronized zinc oxide offers the widest UV spectrum covering from UV-C
through UV-A to 400 nm. However, such a combination is no longer permitted by the
FDA in any new products and would be deemed misbranded and subject to seizure. Even
though the combination was promoted in a June 2000 news report on KABC TV in Los Angeles,
it would only pertain to currently marketed products, and those must be reformulated to
eliminate the combination prior to May 2001 or face being deemed misbranded. In
fact, Avobenzone may not be combined with aminobenzoic acid (PABA), Padimate O,
phenylbenzimidazole sulfonic acid, titanium dioxide, or zinc oxide in any preparation.
Combining cinoxate or oxybenzone with avobenzone would provide coverage for UV-B
and the upper range of UV-C and would be FDA approved combinations. Such a
combination would afford ideal protection from UV-B and UV-A, providing the SPF value of
the product is at least 15. A product with such a combination of ingredients with an
SPF value of at least 15 may not allow much of a tan to form in a single visit to the
beach, which may be ideal for beach volleyball players who prefer a slow deep tan.
Likewise, a product with a combination of sulisobenzone and cinoxate would provide
complete coverage for UV-B and partial coverage for UV-A up to 375 nm, which would allow a
tan to form at a faster rate, while still offering sunburn protection. However,
sulisobenzone is easily removed by swimming, so such a product would not be water
resistant or offer full protection after swimming. The FDA panel recommends that
sunscreen be reapplied after swimming to maintain protection. Use the figure as an
aid in selecting and comparing sunscreen products that will protect you from harmful UV-B
radiation and some or all UV-A radiation.
Previous
Page  |
Next Page |
Copyright 2000
Solumedia and Douglas Barcon, Pharm.D. All rights reserved. This information
and graphics may not be published, duplicated, or transmitted in any manner without the
express written permission of Solumedia and the author.
This page was last updated on 04/29/05. |